Skip to main content
OpenTrials
Completed

NCT Number: NCT06510673

Effect of Extracorporeal Shockwave Therapy, High Power-LASER & Platelet-rich Protein on Pain and Function in Patients With Calcaneal Spur A Randomized Comparative Study.

PURPOSE: To compare the effect of Extracorporeal shock wave therapy and high-power LASER therapy for the treatment of patients with calcaneal spur Background: Calcaneal spur is a common musculoskeletal disorder of the foot that affect the quality-of-life Conservative treatment modalities include, cold application, platelet-rich plasma therapy (PRP), shoe modification, therapeutic ultrasound, extracorporeal shock wave therapy (ESWT), laser therapy (LLLT) are commonly used in the treatment of calcaneal spur.

HYPOTHESES: There will be difference between Extracorporeal shock wave therapy and High- power LASER therapy on pain intensity in patients with calcaneal spur There will be difference between Extracorporeal shock wave therapy and High- power LASER therapy on function in patients with calcaneal spur. There will be difference between Extracorporeal shock wave therapy and High- power LASER therapy on the size of calcaneal spur in patients with calcaneal spur.

RESEARCH QUESTION: Is there any difference between the effect of Extracorporeal shock wave therapy and High-power LASER on calcaneal spur?

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Calcaneal Spur Bone Diseases Exostoses Foot Diseases Heel Spur Hyperostosis Musculoskeletal Diseases

Age range

25 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Badr University in Cairo (BUC)

Cairo, Cairo Governorate, 12311, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

diagnosed with calcaneal spur based on clinical examination and radiological findings.

Exclusion criteria

were as follows: acute trauma to the foot, history of fracture or surgery, lower extremity neurological deficit, polyneuropathy, radicular pain, autoimmune diseases tumor, thrombosis, soft tissue or bone infection, or skin disorder.

Treatment and study plan

Platelet rich plasma

Drug

Platelet-rich plasma for the heel

High power LASER

Other

High power LASER sessions for the heel

Shockwave Therapy

Other

Shockwave therapy sessions for the heel

Sham Laser

Other

Sham LASER for the heel

Primary outcomes

  1. Pain Visual Analog Scale

    Time frame: Baseline and after one month

    It is a self reported outcome which is a 10 cm line with zero at one end indicating no pain and 10 at the other end indicating maximum pain. Patient will be asked to mark the current pain on the scale and the distance from the starting point (0) will be measured

  2. foot function index.

    Time frame: Baseline and after one month

    measure the impact of foot pathology on function in terms of pain, disability and activity restriction. it is a self-administered index

  3. calcaneal Spur length

    Time frame: Baseline and after one month

    Spur length will be measured by MRI

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Collaborators

  • Badr University
  • Helwan University
  • Suez University

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jul 19, 2024
Registry last updated
Jun 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.